Dimethylamine

Dimethylamine

SCHEMBL5887448

CNC.Cc1nc(N2CCc3ccccc3C2)nc2c1ccc(=O)n2-c1ccc(C(=O)NCCCO)cc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.42
LMNA P02545 2/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
NAMPT P43490 1/20 0.38
ADAMTS4 O75173 5/20 0.37
HPGD P15428 2/20 0.37
SCN9A Q15858 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
NAPEPLD Q6IQ20 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887054 0.91 HDAC6 (0.46) HDAC6LMNADRD2DRD3NAMPT
SCHEMBL5887061 0.89 LMNA (0.43) HDAC6LMNADRD2DRD3NAMPT
SCHEMBL5887059 0.89 HDAC6 (0.41) HDAC6LMNADRD2DRD3NAMPT
SCHEMBL5887024 0.88 MAPT (0.44) HDAC6LMNANAMPTADAMTS4HPGD
SCHEMBL5886750 0.86 ADAMTS4 (0.45) LMNANAMPTADAMTS4ALDH1A1MAPT
SCHEMBL5887343 0.86 PRMT5 (0.43) HDAC6LMNAADAMTS4PRMT5WDR77
Dimethylamine SCHEMBL5887374 0.85 KDM4E (0.41) HDAC6DRD2DRD3MAPK8MAPK9
SCHEMBL5887057 0.85 DRD2 (0.41) HDAC6LMNADRD2MAPK8MKNK1
SCHEMBL5886901 0.84 NAPEPLD (0.45) NAMPTADAMTS4PRMT5WDR77NAPEPLD
SCHEMBL5886722 0.83 RXRA (0.46) ADAMTS4SCN9AALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP HDAC6 1835/4885LMNA 711/4885DRD2 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.